Newly refreshed International Research Review Board

MS Research Australia’s International Research Review Board helps guide the strategy that leverages Australia’s strengths, to best contribute to the global effort in MS research. Chaired by Australia’s Professor Bill Carroll, it has three other members- Professor Gavin Giovannoni (London, UK), Professor Richard Ransohoff (Boston, US) and Professor Trevor Kilpatrick (Australia).

All four members are extremely well known in their respective fields of MS research and treatment and they bring critical oversight and an important sounding board to our MS research funding initiatives. Professor Simon Broadley, Chair of our Research Management Council (RMC) which oversees our grant giving processes says that ‘it is important and advantageous to ensure MS Research Australia has rigorous and experienced oversight, so that unbiased advice can be given on which areas we should concentrate our hard earned funds.’

The first meeting of our refreshed review Board recently took place in Washington to take advantage of all four members being present for the recent American Academy of Neurology meeting which was taking place in the capital.

A number of important items were discussed but one of the themes was the importance of international collaborations. It was noted the importance of collaborations to be initiated and/or monitored for a range of fields including MS in young children and adolescents and, of course for progressive MS. The global Board also noted the important role that MS Research Australia should play in the Asia-Pacific region via the Pan-Asian Committee for Treatment and Research in MS (PACTRIMS).

One of the key goals of MS Research Australia is to always play on the strengths of Australian MS research. The Board has identified some of the following areas of research that could be further leveraged with additional funding – this includes the genomic study of MS, the role of the Epstein – Barr virus (EBV) in MS, photo-immunology, creating uniform magnetic resonance imaging (MRI) metrics and the role of large data sets and how we get the most information out of this data to benefit people with MS.


New campaign shines light on life-changing MS Nurse Care

MS Australia has today launched a new campaign at Parliament House on World MS Day (30 May) to raise awareness of the crucial role played by MS Nurses.

Revolutionising MS Treatment: New form of Tysabri® recommended for PBS listing

The Pharmaceutical Benefits Advisory Committee (PBAC) has recommended the listing of natalizumab (Tysabri®) pre-filled syringe for subcutaneous (under the skin) injection on the Pharmaceutical Benefit Scheme (PBS).

What us to keep you in the loop? Subscribe today!

  • Enter your details

Read More

Newsletter subscription

  • Enter your details

Newly refreshed International Research Review Board